Ravi Sirimamilla

Senior Executive in Biocon..!! Ex. Strides Bangalore!! Ex. Piramal Hyderabad!! Ex. Laurus Vizag!!

Role: Senior Executive at Biocon
Location: Bengaluru South, KA, IN
LinkedIn followers: 500 followers

General Business & ManagementView LinkedIn profile

About Ravi Sirimamilla

Executing the Raw Material testing for Oncology and Potent Molecules.* Handling…

Experience

Senior Executive
Biocon
Feb 2025 — Present · Bengaluru, IN
Executing the Raw Material Analysis,* Handling instruments like,* HPLC & UHPLC* Particle Size ize Distribution(PSD),* X-Ray Diffraction(XRD),* AAS,* Potentiometer,* UV-Visible Spectroscopy.* Knowledge on Preparation of analytical method validation protocol and report.* Daily Execution of analytical method validation as per protocol.* Quarterly Calibration of Standalone instruments and analytical Balance daily verifications.*Having experience of Operation of Labware LIMS 7.2 Application.* Initiation of OOS, OOT and deviations.

Education

Grey friars junior college Dondapudi
10+2, MPC
Surya degree College
Bsc, Mathematics
Adikavi Nannaya University
Master's degree, Analytical Chemistry
Z P High school Rajampalem
SSC

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@biocon.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Biocon

Biotechnology Research · 12K employees · Bangalore, Karnataka, India

Fraudulent Recruitment Advisory: Biocon and its subsidiaries never charge candidates any fee at any stage of recruitment. Learn how to identify and report fraudulent job offers: https://www.biocon.com/fraudulent-recruitment-advisory/ Biocon Limited (BSE: 532523, NSE: BIOCON) is a global biopharmaceutical company driven by its purpose to provide affordable, life-changing medicines to patients worldwide. Headquartered in Bengaluru, India, Biocon addresses some of the world’s most pressing healthcare challenges across chronic and non-communicable diseases by offering both biosimilars and generics at scale across geographies. Through this diversified portfolio, Biocon focuses on areas of high unmet need, spanning key therapy areas including diabetes, oncology, obesity, cardiovascular diseases, immunology, ophthalmology, and bone health. The Company has pioneered several industry firsts that have helped shape the global biosimilars landscape. To date, the company has commercialized 12 biosimilar products and 30+ generic formulations globally. It has robust research and development pipeline of 20+ biosimilar assets, as well as GLP-1 peptides and other complex generics. With an integrated lab-to-patient model, Biocon brings together research and development, manufacturing, and commercial capabilities to ensure reliable and scalable supply of medicines. The company operates in more than 120 countries, supported by seven manufacturing sites, three R&D sites, 18 offices worldwide, and a workforce of over 9,500 employees. Biocon has been included in the S&P Global Sustainability Yearbook 2026 for the fourth consecutive year, underscoring its commitment to sustainable and responsible growth.

biocon.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

About Ravi Sirimamilla

Experience

Senior Executive

Education

Grey friars junior college Dondapudi

Surya degree College

Adikavi Nannaya University

Z P High school Rajampalem

Find verified contacts for anyone on LinkedIn